elix.ai Revenue and Competitors
Estimated Revenue & Valuation
- elix.ai's estimated annual revenue is currently $435k per year.
- elix.ai's estimated revenue per employee is $72,500
Employee Data
- elix.ai has 6 Employees.
- elix.ai grew their employee count by 0% last year.
elix.ai's People
Name | Title | Email/Phone |
---|
elix.ai Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 29 | 4% | N/A | N/A |
#2 | $43.4M | 272 | 8% | N/A | N/A |
#3 | $14.1M | 97 | 11% | N/A | N/A |
#4 | $1460M | 8291 | 7% | $1.1B | N/A |
#5 | $310M | 1527 | 20% | N/A | N/A |
#6 | $194.1M | 956 | -5% | N/A | N/A |
#7 | $223.9M | 1080 | -33% | $101.6M | N/A |
#8 | $581.3M | 2708 | 9% | $253.1M | N/A |
#9 | $716.2M | 3528 | 2% | N/A | N/A |
#10 | $801.4M | 3948 | 52% | N/A | N/A |
What Is elix.ai?
PatienTrials Inc, a company of Elix Labs, aims to improve patient retention and adherence in clinical trials that results in shorter study timelines. By putting Patients First in Clinical Trials, empowering them with the information on progress of treatment at their fingertips in a community setting promotes self care. PatienTrials captures high quality patient generated data through solutions based on instant messaging, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring in clinical trials on to a HIPPA compliant instant messaging platform. Check out our solutions at https://www.patienTrials.com
keywords:N/AN/A
Total Funding
6
Number of Employees
$435k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | -14% | N/A |
#2 | $0.4M | 6 | 20% | N/A |
#3 | $0.6M | 6 | -57% | N/A |
#4 | $0.4M | 6 | -40% | N/A |
#5 | $0.4M | 6 | 0% | N/A |